W. Nicholas Haining

Nicholas Haining is a leader in understanding T cell exhaustion and immunotherapy resistance mechanisms. His research using single-cell genomics has revealed the molecular programs underlying T cell dysfunction in cancer and identified strategies to reinvigorate exhausted T cells. Haining's work at Merck focuses on translating these insights into novel immunotherapy approaches.

Nicholas Haining是理解T细胞耗竭和免疫治疗耐药机制的领导者。他使用单细胞基因组学的研究揭示了癌症中T细胞功能障碍的分子程序，并确定了重新激活耗竭T细胞的策略。Haining在默克的工作专注于将这些见解转化为新型免疫治疗方法。